Triptorlin

Developed for: central precocious puberty
Investigated by: Ruijin Hospital · Shanghai Children's Hospital · Shanghai Children's Medical Center · Xin Hua Hospital of Zhejiang Province

today NCT02920515 · Ph 4

201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT02920515	Sep 2012 → Aug 2015	central precocious puberty	Ruijin Hospital	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Triptorlin	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02920515 ↗